Thu, Oct 2, 2014, 11:35 AM EDT - U.S. Markets close in 4 hrs 25 mins

Recent

% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

  • t_rextile_dysfunction t_rextile_dysfunction May 1, 2013 5:49 PM Flag

    May 8 CC & data , in case you didnt already know

     

    Genomic Health Announces Investor Webcast and Conference Call to Review Positive Clinical Validation and Development of the Oncotype DX® Prostate Cancer Test on Wednesday, May 8, 2013

    Complete Results from UCSF-Led Validation Study to be Presented Earlier that Day at the American Urological Association (AUA) Annual Meeting in San Diego

    Collaborators from the University of California, San Francisco (UCSF) and the Cleveland Clinic to Join Management Team

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • you beat me to it - )
      This data is very powerful and long time investors know that this indication will blow the doors off breast/ colon test. THE most unnecessary surgery procedure in the past has been prostate surgery.This test will save insurance companies a gazillion.Launch in a few weeks or about the time I visit Redwood city )
      Good Luck

 
GHDX
28.19-0.35(-1.23%)11:34 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.